Medicine and Dentistry
Infection
48%
COVID-19
42%
Severe Acute Respiratory Syndrome Coronavirus 2
36%
Vaccine
36%
Patient
23%
Antibody
22%
Antibody Response
22%
Neutralizing Antibody
21%
Monoclonal Antibody
21%
Immunogenicity
20%
Disease
17%
T-Cell Response
14%
Immunity
13%
Epitope
13%
Assay
12%
Hospital
12%
Inpatient
11%
Diagnosis
11%
Evaluation Study
11%
Child
11%
Symptom
11%
Immunosuppressive Treatment
11%
Single Drug Dose
10%
Amino Terminal Sequence
10%
Association
10%
Chronic Myelogenous Leukemia
9%
Assessment
9%
Observational Study
9%
mRNA Vaccine
9%
Prognosis
9%
Patient with Cancer
9%
Interim Analysis
9%
Serositis
9%
Syndrome
9%
Cohort Analysis
9%
Immunoassay
9%
Heme
9%
Metabolite
9%
Methotrexate
9%
Nuclear Receptor Coactivator
9%
Receptor Binding
7%
Biological Product
7%
Psoriasis
6%
Seroprevalence
5%
Immune Response
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
42%
Neutralization
33%
COVID-19
32%
Monospecific Antibody
28%
Antibody Response
27%
Neutralizing Antibody
25%
Epitope
22%
Monoclonal Antibodies
21%
Vaccine Efficacy
17%
Immunity
13%
Amino Terminal Sequence
13%
Mutation
13%
Immunity
12%
Receptor Binding
10%
Sample
10%
Metabolite
9%
Dynamics
9%
Human
9%
Breakthrough Infection
9%
Flow
9%
Association
9%
Heme
9%
Nuclear Receptor Coactivator
9%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
30%
Immunity
20%
Antibody
20%
Metabolite
19%
Spike
18%
N-Terminus
14%
Association
9%
TMPRSS2
9%
Nuclear Receptor Coactivator
9%
Neutralizing Antibody
7%